Regeneron Pharma: Federal Court Jury Found Amgen Liable For Violating Antitrust And Tort Laws By Using Cross-Therapeutic Bundled Rebates To Prevent Praluent From Competing In Market; Jury Awarded Regeneron $135.6M Of Compensatory Damages And $271.2M...
Natera Analyst Ratings
Bayer Exec: Trump Pharma Tariffs Would Negatively Impact R&D
IQVIA Hldgs Analyst Ratings
Is the Market Bullish or Bearish on Gilead Sciences?
Bristol CEO Boerner Says Other Countries Should 'Pay More' for US Pharma Innovation
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Key Inflation Data
Disdained by the market! Goldman Sachs: Today's pharmaceutical stocks are like "Coal Industrial Concept during the ESG peak period".
Goldman Sachs traders believe that the current trading performance of pharmaceutical stocks resembles "Energy stocks at the peak of the ESG era - as if they are about to perish," with the Sector's valuation relative to the S&P 500 Index having fallen to a historic low, creating the largest discount on record.
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030
Shares of Pharmaceutical Stocks Are Trading Lower. The Sector May Down on Continued Weakness Amid President Trump's Drug Pricing Executive Order.
Beyond The Numbers: 16 Analysts Discuss Regeneron Pharmaceuticals Stock
Sector Update: Health Care Stocks Rise Premarket Wednesday
This Biotech's Stock Rockets on Oral Obesity Drug Partnership With Wegovy Parent
This PVH Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Regeneron Pharmaceuticals Analyst Ratings
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
A Look Into Mettler-Toledo Intl Inc's Price Over Earnings
Tamboran And Daly Waters Energy Sign Binding Agreement To Finalize Checkerboard Of Joint Acreage Position Across EPs 76, 98 And 117; DWE To Buy Non-Operating, Non-Controlling Interest In 100,000 Acres For US$15M
Sector Update: Health Care Stocks Mixed Premarket Tuesday